XML 19 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Common stock
Treasury stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (AOCI)
Non- controlling interests
Beginning balance at Dec. 31, 2014 $ 448,756 $ 46 $ (53,807) $ 3,553,430 $ (3,069,241) $ 40 $ 18,288
Beginning balance (in shares) at Dec. 31, 2014   46,405,000 5,892,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation expense related to stock appreciation rights (SARs) and stock options 398     398      
Equity-based compensation related to deferred stock units (DSUs) 234     234      
Equity-based compensation related to restricted stock (RS) 23,120     23,120      
Issuance of DSUs 82     82      
Issuance of DSUs (in shares)   94,000          
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (4,170) $ 1   (4,171)      
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (in shares)   253,000          
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (100)     (100)      
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (in shares)   11,000          
Impact of redeemable noncontrolling interests accretion (4,704)     (4,704)      
Impact of subsidiary equity transactions (4,803)     (4,441)     (362)
Repurchase of common stock $ (1,702)   $ (1,702)        
Repurchase of common stock (in shares) (5,598,094)   (96,000)        
Net income (loss) $ (99,140)       (96,080)   (3,060)
Ending balance at Dec. 31, 2015 357,971 $ 47 $ (55,509) 3,563,848 (3,165,321) 40 14,866
Ending balance (in shares) at Dec. 31, 2015   46,763,000 5,988,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation expense related to stock appreciation rights (SARs) and stock options 128     128      
Equity-based compensation related to deferred stock units (DSUs) 341     341      
Equity-based compensation related to restricted stock (RS) 11,390     11,390      
Issuance of DSUs 0     0      
Issuance of DSUs (in shares)   0          
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (1,574) $ 0   (1,574)      
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (in shares)   (267,000)          
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (254)     (254)      
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (in shares)   27,000          
Impact of redeemable noncontrolling interests accretion (599)     (599)      
Impact of subsidiary equity transactions 5,719     4,924   59 736
Repurchase of common stock $ (74,265)   $ (74,265)        
Repurchase of common stock (in shares) (2,175,268)   (5,598,000)        
Net income (loss) $ 66,627       70,085   (3,458)
Ending balance at Dec. 31, 2016 365,484 $ 47 $ (129,774) 3,578,204 (3,095,236) 99 12,144
Ending balance (in shares) at Dec. 31, 2016   46,523,000 11,586,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation expense related to stock appreciation rights (SARs) and stock options 118     118      
Equity-based compensation related to deferred stock units (DSUs) 430     430      
Equity-based compensation related to restricted stock (RS) 14,683     14,683      
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (15,965) $ (1)   (15,964)      
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (in shares)   (882,000)          
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (1)     (1)      
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (in shares)   0          
Impact of redeemable noncontrolling interests accretion 2,121     2,121      
Impact of subsidiary equity transactions (8,186)     2,338   (99) (10,425)
Repurchase of common stock (30,434)   $ (30,434)        
Repurchase of common stock (in shares)     (2,176,000)        
Net income (loss) 172,239     0 173,958   (1,719)
Ending balance at Dec. 31, 2017 $ 500,489 $ 46 $ (160,208) $ 3,581,929 $ (2,921,278) $ 0 $ 0
Ending balance (in shares) at Dec. 31, 2017   45,641,000 13,762,000